Surmodics, Inc.
Surmodics provides performance coating technologies for intravascular medical devices and IVD tests/microarrays. It operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment offers surface modification coatings and drug-delivery coatings for various markets. The IVD segment develops, manufactures, and sells chemical/biological components for IVD immunoassay and molecular tests.
Overview
Strengths
- No significant strengths identified based on the analyzed metrics.
Weaknesses
- With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
- Analysts expect revenues to decline in the coming year.
- The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
- The company have lower returns than the sector in which it operates. ROIC (0.16%) is significantly lower than the sector mean (2.97%).
- EV/EBIT (100.00) is significantly higher than the sector mean.
- EBITDA Margin (2.42%) appears relatively low.
Key Financial Data
| Indicator | Value |
|---|
| PER | 100.0 |
| EV/EBITDA | 168.3 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | 0.2% |
| Net Debt/EBITDA | 100.0 |